Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis
PRODUCT SPECIFICATIONS Form: Lyophilized powder Purity: 99%+ (HPLC verified) Third-Party Lab Tested: Yes Storage: Store at -20C, protect from light and moisture Reconstitution: Use Bacteriostatic Water or Acetic Acid Water (sold separately) RESEARCH USE ONLY DISCLAIMER FOR RESEARCH USE ONLY
Use an alcohol swab to disinfect the rubber top of the vial and dispose of the swab properly
Wadden and Brown noted that their studys findings for semaglutide are consistent with results of the FDAs most recent analysis of post-marketing surveillance data for this class of medications which did not find evidence that use of these medicines causes suicidal thoughts or actions. If you or a loved one are experiencing a suicidal crisis or emotional distress call the Suicide and Crisis Lifeline at 988
When to talk to your doctor If you notice persistent mood changes during GLP1 treatment, dont dismiss them or assume theyre unrelated
Adverse effects Besides nausea which was more frequent in the GLP-1RA group (40 vs 4%), there was no difference in the occurrence of adverse effects
